Patents as a Driver of the Unprecedented Biomedical Response to COVID-19
The response by the biotech and pharmaceutical sectors to the COVID-19 pandemic has been historically unprecedented. Vaccines based in cutting-edge technologies, such as the mRNA platform, were invented, tested, and distributed to patients in less than a year. Yet politicians and activists argue tha...
Saved in:
Main Authors: | Adam Mossoff JD (Author), Amesh Adalja MD (Author) |
---|---|
Format: | Book |
Published: |
SAGE Publishing,
2022-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
COVID-19: An unprecedented crisis that needs an extraordinary response
by: Tabish SA
Published: (2020) -
At-home infectious disease testing: An idea whose time has come
by: Amesh A. Adalja
Published: (2022) -
Anthrax: has the clinical milieu changed since 2001?
by: Amesh A. Adalja
Published: (2012) -
Challenge and response: Cleft care in an unprecedented pandemic
by: Mamta Carroll
Published: (2021) -
The unprecedented surge of dengue in the Americas: Strategies for effective response
by: Ashutosh Pareek, et al.
Published: (2024)